凝固検査のアメリカ市場2017-2021

◆英語タイトル:2017-2021 US Coagulation Testing Market: Growth Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers
◆発行会社/調査会社:Venture Planning Group
◆商品コード:DATA70209037
◆発行日:2017年2月7日
◆調査対象地域:アメリカ
◆産業分野:医療
◆ページ数:424
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Local PDF(同一事業所内共有可)USD9,600 ⇒換算¥1,075,200見積依頼/購入/質問フォーム
Global PDF(全事業所で共有可)USD21,100 ⇒換算¥2,363,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
Venture Planning Group社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[凝固検査のアメリカ市場2017-2021]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

Complete report $9,600.  DataPack (test volumes, sales forecasts, supplier shares) $6,200.

Summary

This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the next five years.

The report explores business and technological trends in the US coagulation testing market; provides estimates of the test volume, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.

Coagulation Tests

Activated Clotting Time (ACT) (1), Activated Protein C Resistance,
Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time,
D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII,  Factor IX,
Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII,
Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation,
Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen,
Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S,
Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time,
Von Willebrand’s Factor Fav/Ag, and others.

Sales and Market Share Analysis

- Sales and market shares of major
instrument and reagent suppliers.

Competitive Assessments

- Extensive strategic profiles of
major suppliers and emerging market entrants.

Market Segmentation Analysis

- Comprehensive market
segmentation analysis, including:

   – Hospitals
   – Commercial/Private Laboratories
   – Physician Offices

- Test volume forecasts for over 40 major procedures
by market segment.

Current and Emerging Products

- Review of established and emerging procedures.

- Comparison of automated and semi-automated
analyzers from Diagnostica Stago, Helena, IL,
Siemens, Sysmex and other suppliers.

Technology Review

- Analysis of current and emerging technologies
and their potential market applications.

- Comprehensive lists of companies developing
or marketing new technologies and products by test.

Strategic Recommendations

- Product development and business expansion
opportunities with significant market appeal.

- “Ideal” product models with tentative
prices and operating characteristics.

- Alternative market penetration
strategies for instrument and reagent suppliers.

- Potential market entry barriers and risks.

Contains 424 pages and 37 tables


This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the next five years. 

The report explores business and technological trends in the US coagulation testing market; provides estimates of the test volume, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.

Coagulation Tests

Activated Clotting Time (ACT) (1), Activated Protein C Resistance,
Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time,
D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII,  Factor IX,
Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII,
Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation,
Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen,
Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S,
Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time,
Von Willebrand's Factor Fav/Ag, and others.



*** レポート目次(コンテンツ)***

http://www.vpgcorp.com/webfiles/Coagulation/TOCLOT%20USCoagTestingMarketSalesForecastsSupplierSharesCompetitiveStrategies.pdf

http://www.vpgmarketresearch.com/pdffiles/LOTUSCoagTestingMarketSalesForecastsSupplierSharesCompetitiveStrategies.pdf

*** レポートのキーワード ***

凝固検査

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DATA70209037 )"凝固検査のアメリカ市場2017-2021" (英文:2017-2021 US Coagulation Testing Market: Growth Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers )はVenture Planning Group社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。